Enhancement of immune response mediated by oropharyngeal colostrum administration in preterm neonates.
Jorge Moreno-FernandezBelén Sánchez-MartínezLaura Serrano-LópezEstefanía Martín-ÁlvarezJavier Diaz-CastroManuela Peña-CaballeroFrancisca Martín-PeregrinaMercedes Alonso-MoyaJosé Maldonado-LozanoJulio J OchoaJose A Hurtado-SuazoPublished in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2018)
Oropharyngeal colostrum administration is safe in preterm neonates and improves their immunologic profile, showing a potential role as an immunomodulatory agent.